MediWound Ltd. MDWD
Key Stats
- Today's Range
- $14.29 – $14.74
- 50-Day Range
- $13.54 – $17.10
- 52-Week Range
- $13.54 – $21.25
- Volume
- 76K shs
- Average Volume
- 81K shs
- Market Cap
- $184.43 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.94%
- Days to Cover
- 2.91
About MediWound Ltd.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.